Non-organ-specific and anti-endothelial antibodies in relation to CMV infection and acute rejection in renal transplant recipients

Clinical Transplantation

Volumn 24, Issue 4, 2010, Pages 488-492

  Costa, Cristina ^a   Touscoz, Giovanni Antonio ^b   Bergallo, Massimiliano ^a   Terlizzi, Maria Elena ^a   Astegiano, Sara ^a   Sidoti, Francesca ^a   Sinesi, Franca ^a   Segoloni, Giuseppe P ^c   Cavallo, Rossana ^a  

^a Department of Public Health and Microbiology   (Italy)

^b SCDU Gastro Hepatology   (Italy)

^c Transplantation Unit   (Italy)

Author keywords

Anti endothelial cell antibodies; Cytomegalovirus; Non organ specific autoantibodies; Rejection; Renal transplantation

Indexed keywords

AUTOANTIBODY; CYTOMEGALOVIRUS ANTIGEN PP65; ENDOTHELIAL CELL ANTIBODY; NON ORGAN SPECIFIC ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ACUTE VASCULAR REJECTION; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ENDOTHELIUM LESION; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTERSTITIUM; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATHOGENICITY; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; AUTOANTIBODIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955726376     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01092.x     Document Type: Article

References (19)

1. Paroli M, Schiaffella E, Di Rosa F, Barnaba V. Persisting viruses and autoimmunity. J Neuroimmunol 2000, 107:201.
2. Baldwin WM, Westedt ML, van Gemert GW. Association of rheumatoid factors in renal transplant recipients with cytomegalovirus infection and not with rejection. Transplantation 1987, 43:658.
3. Rider JR, Ollier WE, Lock RJ, Brookes ST. Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 1997, 15:405.
4. Toyoda M, Galfayan K, Galera OA, Petrosian A, Czer LS, Jordan SC. Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients. Transpl Immunol 1997, 5:104.
5. Varani S, Muratori L, De Ruvo N. Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: correlation with antigenemia. J Med Virol 2002, 66:56.
6. Sagedal S, Hartmann A, Rollag H. The impact of early cytomegalovirus infection and disease in renal transplant recipients. Clin Microbiol Infect 2005, 11:518.
7. Costa C, Bergallo M, Cavallo R. Role of antiviral prophylaxis in renal transplant recipients at high risk of cytomegalovirus infection. J Clin Virol 2008, 42:293.
8. Bergallo M, Costa C, Tarallo S. Development of a quantitative-competitive PCR for quantification of human cytomegalovirus load and comparison with antigenaemia, viraemia and pp67 RNA detection by nucleic acid sequenze-based amplification. Panminerva Med 2006, 48:119.
9. Costa C, Bergallo M, Touscoz GA. Non-organ-specific autoantibodies and CMV infection in renal transplant recipients with or without rejection. Transplantationsmedizin 2007, 19:39.
10. Mengarelli A, Minotti C, Palumbo G. High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation. Br J Haematol 2000, 108:126.
11. Lenzi M, Bellentani S, Saccoccio G. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 1999, 45:435.
12. Razonable RR. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. Am J Health Syst Pharm 2005, 62(Suppl 1):S7.
13. Van Dam-Mieras MC, Muller AD, Van Hinsbergh VWM, Mullers WJ, Bomans PH, Bruggeman CA. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 1992, 68:364.
14. Sedmak DD, Knoght DA, Vook NC, Waldman JW. Divergent patterns of ELAm-1, ICAm-1, and VCAm-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 1994, 58:1379.
15. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis 1998, 177:1465.
16. Söderberg-Nauclér C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 2006, 259:219.
17. Kooijmans-Coutinho MF, Hermans J, Schrama E. Interstitial rejection, vascular rejection, and diffuse thrombosis of renal allografts: predisposing factors, histology, immunochemistry, and relation to outcome. Transplantation 1996, 61:1338.
18. Toyoda M, Petrosian A, Jordan SC. Immunological characterization of anti-endothelial cell antibodies induced by citomegalovirus infection. Transplantation 1999, 68:1311.
19. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti-endothelial cell antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum 2001, 44:1484.